Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: | Active, not recruiting |
---|---|
Conditions: | Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 22 - Any |
Updated: | 11/28/2018 |
Start Date: | October 2013 |
End Date: | June 2019 |
The purpose of this study is to evaluate the safety and effectiveness of an artificial iris
prosthesis for the treatment of iris defects.
prosthesis for the treatment of iris defects.
Inclusion Criteria:
1. 22 years of age or older
2. Having a diagnosis of congenital or acquired full or partial iris defect in the study
eye.
3. Having symptoms of light sensitivity, photophobia, and/or glare in the study eye.
4. Subjects should be pseudophakic, aphakic or require cataract extraction.
5. Signed and received a copy of the signed written informed consent.
6. Willingness and ability to comply with schedule for follow-up visits and postoperative
evaluations.
Exclusion Criteria:
1. Uncontrolled ocular inflammation (e.g., uveitis).
2. Preoperative intraocular pressure > 21 mm Hg.
3. Subjects with a current condition that, in the investigator's opinion, would interfere
with the treatment.
4. Subjects with any of the following conditions:
1. Severe chronic uveitis
2. Microphthalmus
3. Untreated retinal detachment
4. Untreated chronic glaucoma
5. Rubella cataract
6. Rubeosis of the iris
7. Proliferative diabetic retinopathy
5. Female subjects who are pregnant or lactating at the time of surgery.
6. Subjects with a known sensitivity to required postoperative study medications (4th
generation fluoroquinolone or steroid anti-inflammatory) if an alternative medication
is not available.
7. Subjects under legal guardianship or who, in the investigator's opinion, lack the
mental capacity to provide written informed consent for study participation.
8. Stargardt's retinopathy.
9. Subjects with gastric ulcers or diabetes mellitus in whom high doses of postoperative
steroids are required.
10. Surgical difficulty of the planned surgery, which might increase the potential for
complications.
11. No useful vision or vision potential in the fellow eye.
12. Clear crystalline lens.
13. Implantation of a CustomFlex Artificial Iris prosthesis in the contralateral eye
within the previous 4 weeks.
14. In the investigator's opinion, the presence of a condition or finding in the
contralateral eye that would make it unsafe to implant a CustomFlex Artificial Iris
prosthesis in the study eye.
We found this trial at
12
sites
Salt Lake City, Utah 84107
Principal Investigator: Robert Cionni, M.D.
Phone: 801-263-5757
Click here to add this to my saved trials
100 Stein Plaza
Los Angeles, California 90095
Los Angeles, California 90095
Principal Investigator: Kevin Miller, M.D.
Phone: 310-206-1634
Click here to add this to my saved trials
Astoria, New York 11103
Principal Investigator: Richard J. Mackool, M.D.
Phone: 718-728-3400
Click here to add this to my saved trials
Atlanta, Georgia 30339
Principal Investigator: Stephen Hamilton, MD
Phone: 404-351-2220
Click here to add this to my saved trials
Bloomington, Minnesota 55431
Principal Investigator: David Hardten, M.D.
Phone: 801-581-2352
Click here to add this to my saved trials
Cincinnati, Ohio 45242
Principal Investigator: Michael Snyder, M.D.
Phone: 513-984-5133
Click here to add this to my saved trials
Click here to add this to my saved trials
Great Neck, New York 11023
Principal Investigator: Kenneth Rosenthal, M.D.
Phone: 516-504-9361
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Doug Koch, M.D.
Phone: 713-798-4125
Click here to add this to my saved trials
Indianapolis, Indiana 46260
Principal Investigator: Francis Price, M.D.
Phone: 317-844-5530
Click here to add this to my saved trials
Los Angeles, California 90067
Principal Investigator: Samuel Masket, M.D.
Phone: 310-229-1220
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
Principal Investigator: Brandon Ayres, M.D.
Phone: 877-289-4557
Click here to add this to my saved trials